Radu Pislariu

Radu Pislariu Email and Phone Number

President and CEO at Laurent Pharmaceuticals @ Laurent Pharmaceuticals
montréal, quebec, canada
Radu Pislariu's Location
Canada, Canada
Radu Pislariu's Contact Details

Radu Pislariu personal email

n/a
About Radu Pislariu

Experienced healthcare entrepreneur, investor and executive, with extensive medical and drug development expertise. Specialties: Entrepreneurship, Venture Capital, Strategic Management, Innovation Transfer, Drug Development, Healthcare

Radu Pislariu's Current Company Details
Laurent Pharmaceuticals

Laurent Pharmaceuticals

View
President and CEO at Laurent Pharmaceuticals
montréal, quebec, canada
Employees:
5
Radu Pislariu Work Experience Details
  • Laurent Pharmaceuticals
    President And Ceo, Co-Founder
    Laurent Pharmaceuticals Nov 2012 - Present
    Montréal
    Laurent Pharmaceuticals is a clinical-stage biopharmaceutical company developing LAU-7b, a small molecule drug targeting host cells membrane lipids involved in antiviral defense, inflammation, and fibrosis. LAU-7b is being evaluated in clinical trials as a potential treatment for Cystic Fibrosis, IPF and Long COVID. See more at www.laurentpharma.com
  • Fundry  -  Shaping Innovation Into Business
    Founder & President
    Fundry - Shaping Innovation Into Business May 2012 - Present
    Montreal, Canada Area
    Fundry is an entrepreneurship platform dedicated to innovation transfer & entrepreneurship, start-up creation and investment structuring.
  • Mimetogen Pharmaceuticals Inc.
    Board Observer
    Mimetogen Pharmaceuticals Inc. Jan 2008 - Mar 2016
    Montreal, Canada Area
    Mimetogen is a clinical-stage biotechnology company developing a novel class of neurotrophin mimetics for the treatment ocular surface diseases . The company is in Phase III clinical development with tavilermide, its lead drug for the treatment of dry eye.
  • Milestone Pharmaceuticals
    Board Observer
    Milestone Pharmaceuticals Jan 2008 - Dec 2015
    Milestone Pharmaceuticals(Nasdaq: MIST) is a Phase 3 clinical cardiovascular company developing a short-acting calcium channel blocker (epitramil) as a rapid-onset nasal spray to terminate episodes of paroxysmal supraventricular tachycardia (PSVT).
  • Msbi Valorisation
    Investment Manager, Life Sciences
    Msbi Valorisation Feb 2007 - Nov 2012
    MSBi Valorisation (now part of Axelys) was a seed capital investment group affiliated with iNovia Capital, and focusing on start-up creation around technologies originating from McGill University, Université de Sherbrooke and Bishop’s University. MSBiV was instrumental for creating several university spin-offs, including Milestone Pharmaceuticals, Mimetogen Pharmaceuticals and Laurent Pharmaceuticals.
  • Inovia Capital
    Senior Associate
    Inovia Capital Aug 2006 - May 2011
    Montreal, Quebec, Canada
    iNovia Capital is a venture firm that partners with audacious founders to build enduring global technology companies. iNovia manages over US $2.2B across early and growth stage funds, and holds offices in Montreal, Toronto, Calgary, San Francisco and London.
  • Allostera Pharma, Inc.
    Board Observer
    Allostera Pharma, Inc. 2007 - 2010
    Allostera Pharma Inc. was a preclinical stage biotech platform company, focusing on a new class of small peptides drugs with allosteric mechanism of action, against different targets primarily focused on inflammation and autoimmunity.
  • Universite Du Quebec En Outaouais
    Innovation Transfer Officer
    Universite Du Quebec En Outaouais Sep 2006 - Feb 2007
    Forum for Research and Innovation in Outaouais (FRIO)

Radu Pislariu Skills

Venture Capital Entrepreneurship Start Ups Technology Transfer Biotechnology Drug Development Strategy Commercialization Life Sciences Pharmaceutical Industry Healthcare Lifesciences Leadership Private Equity Business Strategy Corporate Development Innovation Management Due Diligence Mergers And Acquisitions Start Up Ventures Strategic Planning Business Development Clinical Trials Medical Devices Investments Licensing Emerging Markets International Business Biopharmaceuticals Strategic Partnerships Angel Investing Portfolio Management Clinical Research Finance M&a Experience Technology Evaluation Protein Chemistry Valuation Cleantech Executive Management Restructuring Venture Financing Investor Relations Intellectual Property Capital

Radu Pislariu Education Details

Frequently Asked Questions about Radu Pislariu

What company does Radu Pislariu work for?

Radu Pislariu works for Laurent Pharmaceuticals

What is Radu Pislariu's role at the current company?

Radu Pislariu's current role is President and CEO at Laurent Pharmaceuticals.

What is Radu Pislariu's email address?

Radu Pislariu's email address is rp****@****tal.com

What schools did Radu Pislariu attend?

Radu Pislariu attended Université De Montréal, Hec Montréal, Universitatea De Medicină Și Farmacie „grigore T. Popa”, Romania, Réseau Interval, Montréal, "grigore Moisil" Computers Science High School Iasi, Romania.

What are some of Radu Pislariu's interests?

Radu Pislariu has interest in Digital Photography, Mineralogy, Basketball.

What skills is Radu Pislariu known for?

Radu Pislariu has skills like Venture Capital, Entrepreneurship, Start Ups, Technology Transfer, Biotechnology, Drug Development, Strategy, Commercialization, Life Sciences, Pharmaceutical Industry, Healthcare, Lifesciences.

Who are Radu Pislariu's colleagues?

Radu Pislariu's colleagues are Jean-Marie Houle, Dr Larry C Lands.

Not the Radu Pislariu you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.